Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
AVITA Medical, Inc. (RCEL)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/10/2023 |
8-K
| Quarterly results|
Docs:
|
"AVITA Medical Reports Second Quarter Financial Results VALENCIA, California, August 10, 2023 — AVITA Medical, Inc. , a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today reported financial results for the second quarter June 30, 2023. Financial Highlights and Recent Updates • Commercial revenue of $11.7 million, a 42% increase compared to $8.2 million for the same period in 2022 • Received Food and Drug Administration approval of premarket approval supplement for the use of RECELL to treat full-thickness skin defects on June 7 • Initiated commercial launch of full-thickness skin defects, along with additional eligible burn procedures, with expanded U.S. comm..." |
|
| 11/14/2022 |
8-K
| Quarterly results |
| 08/12/2022 |
8-K
| Quarterly results |
| 05/17/2022 |
8-K
| Quarterly results |
| 03/01/2022 |
8-K
| Quarterly results |
| 08/26/2021 |
8-K
| Investor presentation, Quarterly results |
|
|